U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CUSATUZUMAB
RR5U4UFJ8L
Investigational
General
Names
6
Classification
1
Identifiers
7
Subunits
4
Related Substances
1
CUSATUZUMAB
RR5U4UFJ8L
Investigational
General
Approval Year
Unknown
149,124
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CUSATUZUMAB
Official Name
English
ARGX-110
Preferred Name
English
HUMANIZED-LLAMA DEFUCOSYLATED ANTI-CD70 MONOCLONAL IGG1 ANTIBODY
Common Name
English
cusatuzumab [INN]
Common Name
English
HUMANIZED DEFUCOSYLATED ANTI-CD70 MONOCLONAL IGG1 ANTIBODY
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of acute myeloid leukemia
FDA ORPHAN DRUG
614717
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000181758
PRIMARY
CAS
1399546-01-0
NO STRUCTURE GIVEN
INN
10558
PRIMARY
CAS
1864871-20-4
PRIMARY
DRUG BANK
DB15100
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
RR5U4UFJ8L
CUSATUZUMAB